These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25376085)

  • 21. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
    Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
    Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
    Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
    Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
    Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.
    Cao W; Li H; Zhang J; Li D; Acheampong DO; Chen Z; Wang M
    Protein Expr Purif; 2013 Aug; 90(2):55-66. PubMed ID: 23680780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.
    Yang GW; Jiang JS; Lu WQ
    Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
    Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
    Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
    Luan X; Gao YG; Guan YY; Xu JR; Lu Q; Zhao M; Liu YR; Liu HJ; Fang C; Chen HZ
    Toxicol Appl Pharmacol; 2014 Nov; 281(1):118-24. PubMed ID: 25250884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.
    Deroanne CF; Bonjean K; Servotte S; Devy L; Colige A; Clausse N; Blacher S; Verdin E; Foidart JM; Nusgens BV; Castronovo V
    Oncogene; 2002 Jan; 21(3):427-36. PubMed ID: 11821955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LW-215, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo.
    Zhao K; Yuan Y; Lin B; Miao Z; Li Z; Guo Q; Lu N
    Gene; 2018 Feb; 642():533-541. PubMed ID: 29196258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway.
    Ji L; Wu M; Li Z
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30111763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo.
    Saraswati S; Agrawal SS
    Cancer Lett; 2013 May; 332(1):83-93. PubMed ID: 23348691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling.
    Wan L; Zhao Y; Zhang Q; Gao G; Zhang S; Gao Y; Chen X; Qian X
    BMC Complement Altern Med; 2019 Dec; 19(1):359. PubMed ID: 31823762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
    Pan R; Dai Y; Gao XH; Lu D; Xia YF
    Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway.
    Wu Y; He L; Zhang L; Chen J; Yi Z; Zhang J; Liu M; Pang X
    J Pharmacol Exp Ther; 2011 Nov; 339(2):403-11. PubMed ID: 21828260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
    Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
    Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
    Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.